Not recruiting
Urea cycle disorder+3
Not recruitingLong-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases
InvestigationalNo placebo
Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases
InvestigationalNo placebo
- Disease:Urea cycle disorderInborn error of metabolism+2
- Substances:Hhalpc
Countries:
Belgium
Belgium- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Hhalpc
